Mustafa Özgüroğlu (mzgrolu) - Profile | Pinterest
Cancers | Free Full-Text | Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label,
Christian WÜLFING | Chief of Department | Prof. Dr. med. | Asklepios Klinik Altona, Hamburg | Department of Urology | Research profile
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
Akademik | Prof.Dr.Gökhan Demir
KANSER KEMOTERAPİSİ UYGULAMA İLKELERİ, Fuat H. Demirelli Mustafa Özgüroğlu Gökh - İkinci El Kitap - kitantik | #4522107000297
Mustafa Özgüroğlu - Professor of Medical Oncology - Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine | LinkedIn
Untitled
Mustafa Ozguroglu - AI Profile | 人才画像- AMiner
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - ScienceDirect
İstanbul Üniversitesi - Cerrahpaşa | Hasan Ali Yücel Eğitim Fakültesi Pedagojik Formasyon Sertifika Programları
Assoc. Prof. Şebnem İZMİR GÜNER - Memorial
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-contr
YILIN EN BAŞARILI ONKOLOJİ UZMANI – Türkiye Ödülleri
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO) - Lung Cancer
Prof. Dr. Mustafa Özgüroğlu Yorumlarını oku ve randevu al - Doktorsitesi.com
Cancers | Free Full-Text | Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label,
Mustafa ÖZGÜROĞLU | Professor (Full) | professor | İstanbul University-Cerrahpaşa, Istanbul | Internal Medicine Division of Medical Oncology Clinical Trial Unit | Research profile
Kadıköy Lökoferez Uygulayan Doktorlar/Uzmanlar
